{"id":"https://openalex.org/W2128196636","doi":"https://doi.org/10.1158/1078-0432.ccr-11-2696","title":"Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood","display_name":"Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood","publication_year":2012,"publication_date":"2012-03-16","ids":{"openalex":"https://openalex.org/W2128196636","doi":"https://doi.org/10.1158/1078-0432.ccr-11-2696","mag":"2128196636","pmid":"https://pubmed.ncbi.nlm.nih.gov/22421194","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3533370"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-11-2696","doi":"https://doi.org/10.1158/1078-0432.ccr-11-2696","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-11-2696","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/articles/PMC3533370","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030307166","display_name":"Michaela Jane Higgins","orcid":"https://orcid.org/0000-0002-9065-8652","observed_orcids":["https://orcid.org/0000-0002-9065-8652"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michaela J. Higgins","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075192326","display_name":"Danijela Jelovac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danijela Jelovac","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045172554","display_name":"Evan Barnathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Barnathan","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brian Blair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Blair","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904861","display_name":"Shannon A. Slater","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon Slater","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024051709","display_name":"Penny Powers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Penny Powers","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089577772","display_name":"Jane Zorzi","orcid":"https://orcid.org/0009-0009-8389-5754","observed_orcids":["https://orcid.org/0009-0009-8389-5754"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane Zorzi","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967110","display_name":"Stacie C. Jeter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacie C. Jeter","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051529449","display_name":"George R. Oliver","orcid":"https://orcid.org/0000-0001-5106-8935","observed_orcids":["https://orcid.org/0000-0001-5106-8935"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George R. Oliver","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020382206","display_name":"John H. Fetting","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Fetting","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012487596","display_name":"Leisha A. Emens","orcid":"https://orcid.org/0000-0002-7694-0731","observed_orcids":["https://orcid.org/0000-0002-7694-0731"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leisha Emens","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006060886","display_name":"Carol D. Riley","orcid":"https://orcid.org/0009-0001-3268-3438","observed_orcids":["https://orcid.org/0009-0001-3268-3438"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Riley","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056530735","display_name":"Vered Stearns","orcid":"https://orcid.org/0000-0003-4018-4708","observed_orcids":["https://orcid.org/0000-0003-4018-4708"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vered Stearns","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067305645","display_name":"Frank Diehl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Diehl","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010495394","display_name":"Philipp Angenendt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philipp Angenendt","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082079852","display_name":"Peng Fei Huang","orcid":"https://orcid.org/0000-0003-3011-3359","observed_orcids":["https://orcid.org/0000-0003-3011-3359"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peng Huang","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022931646","display_name":"Leslie Cope","orcid":"https://orcid.org/0000-0002-4098-3289","observed_orcids":["https://orcid.org/0000-0002-4098-3289"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Cope","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111776335","display_name":"Pedram Argani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pedram Argani","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101769237","display_name":"Kathleen M. Murphy","orcid":"https://orcid.org/0000-0001-5840-9384","observed_orcids":["https://orcid.org/0000-0001-5840-9384"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen M. Murphy","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067665770","display_name":"Kurtis E. Bachman","orcid":"https://orcid.org/0000-0001-5387-6207","observed_orcids":["https://orcid.org/0000-0001-5387-6207"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurtis E. Bachman","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051856148","display_name":"Joel D. Greshock","orcid":"https://orcid.org/0000-0001-6567-4266","observed_orcids":["https://orcid.org/0000-0001-6567-4266"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Greshock","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026024346","display_name":"Antonio C. Wolff","orcid":"https://orcid.org/0000-0003-3734-1063","observed_orcids":["https://orcid.org/0000-0003-3734-1063"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Antonio C. Wolff","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091723009","display_name":"Ben Ho Park","orcid":"https://orcid.org/0000-0001-8119-2291","observed_orcids":["https://orcid.org/0000-0001-8119-2291"]},"institutions":[{"id":"https://openalex.org/I1286960001","display_name":"Parkland Health & Hospital System","ror":"https://ror.org/04rt7ps04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286960001"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210100387","display_name":"Propath Services (United States)","ror":"https://ror.org/00jd15125","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100387"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ben H. Park","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","Center for Clinical Innovation, Parkland Health and Hospital System","GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Boston, Massachusetts; 2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 3Center for Clinical Innovation, Parkland Health and Hospital System; 4ProPath, Dallas, Texas 5Inostics, GmbH, Hamburg, Germany; and 6GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210164401"]},{"raw_affiliation_string":"Center for Clinical Innovation, Parkland Health and Hospital System","institution_ids":["https://openalex.org/I1286960001"]},{"raw_affiliation_string":"GlaxoSmithKline, Oncology R&D, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"ProPath, Dallas, Texas Inostics, GmbH, Hamburg, Germany","institution_ids":["https://openalex.org/I4210100387"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5026024346","https://openalex.org/A5091723009"],"corresponding_institution_ids":["https://openalex.org/I1286960001","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210100387","https://openalex.org/I4210114143","https://openalex.org/I4210164401"],"apc_list":null,"apc_paid":null,"fwci":9.4846,"has_fulltext":false,"cited_by_count":307,"citation_normalized_percentile":{"value":0.98910995,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"18","issue":"12","first_page":"3462","last_page":"3469"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9980000257492065},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/beaming","display_name":"beaming","score":0.9279999732971191},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.7570000290870667},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9599999785423279},{"id":"https://openalex.org/keywords/targeted-therapy-response","display_name":"targeted therapy response","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.9205805659294128},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7623934745788574},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6078118085861206},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6029292345046997},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6029187440872192},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5686759352684021},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5505325794219971},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49584588408470154},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.48493650555610657},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4505805969238281},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4453580379486084},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4214846193790436},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3244222402572632},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19315925240516663},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12804114818572998},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11824896931648254}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005819","descriptor_name":"Genetic Markers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-11-2696","doi":"https://doi.org/10.1158/1078-0432.ccr-11-2696","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-11-2696","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:22421194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22421194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2534026","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3533370","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3533370","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3533370","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2534026","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3533370","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G1953150889","display_name":"Laboratory Training Program in Radiation Oncology","funder_award_id":"T32CA121937","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2888788608","display_name":null,"funder_award_id":"CA109274","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3001867404","display_name":"Genetic effectors of TGF-beta induced growth and arrest.","funder_award_id":"R01CA109274","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4402250765","display_name":"SPORE in Breast Cancer","funder_award_id":"P50CA088843","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8074500408","display_name":"Genetic effectors of TGF-beta induced growth and arrest","funder_award_id":"R55CA109274","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000906613","display_name":"Molecular Targets for Cancer Detection and Treatment","funder_award_id":"T32CA009071","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000911005","display_name":"Regional Oncology Research Center","funder_award_id":"P30CA006973","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1494567425","https://openalex.org/W1971754065","https://openalex.org/W1971843650","https://openalex.org/W1988290769","https://openalex.org/W1991472738","https://openalex.org/W2005216767","https://openalex.org/W2015438948","https://openalex.org/W2032518018","https://openalex.org/W2041142042","https://openalex.org/W2043342225","https://openalex.org/W2043696829","https://openalex.org/W2055614052","https://openalex.org/W2057794558","https://openalex.org/W2098900292","https://openalex.org/W2099729090","https://openalex.org/W2101844056","https://openalex.org/W2106036365","https://openalex.org/W2106543129","https://openalex.org/W2106789440","https://openalex.org/W2107945266","https://openalex.org/W2117753040","https://openalex.org/W2118073504","https://openalex.org/W2118934356","https://openalex.org/W2134123784","https://openalex.org/W2137666600","https://openalex.org/W2141134269","https://openalex.org/W2143695256","https://openalex.org/W2144957807","https://openalex.org/W2148617938","https://openalex.org/W2152654745","https://openalex.org/W2154692501","https://openalex.org/W2155311724","https://openalex.org/W2160076878","https://openalex.org/W2165404212","https://openalex.org/W2169895148","https://openalex.org/W2170872221","https://openalex.org/W2257833854","https://openalex.org/W2560367415","https://openalex.org/W4235642752"],"related_works":["https://openalex.org/W228937011","https://openalex.org/W2257682105","https://openalex.org/W2140412193","https://openalex.org/W2099729090","https://openalex.org/W2749060516","https://openalex.org/W2096229729","https://openalex.org/W2789122598","https://openalex.org/W2799525990","https://openalex.org/W2955911683","https://openalex.org/W2324104958"],"abstract_inverted_index":{"PURPOSE:":[0],"We":[1,55],"sought":[2],"to":[3,247],"evaluate":[4],"the":[5,59,75,112,115,140,143,164,189,198,224,240],"feasibility":[6],"of":[7,18,61,96,117,137,154,158,194,200,226,242,245],"detecting":[8],"PIK3CA":[9,51,69,97,118,177,201,215,228],"mutations":[10,52,70,98,178,202],"in":[11,103,188,203],"circulating":[12],"tumor":[13,37,84,160],"DNA":[14,86,168],"(ctDNA)":[15],"from":[16,43,130],"plasma":[17,41,133],"patients":[19,44,63,204],"with":[20,45,64,77,205],"metastatic":[21,65,206],"breast":[22,46,66,207],"cancer":[23,47,67,208],"using":[24,87],"a":[25,33],"novel":[26],"technique":[27],"called":[28],"BEAMing.":[29,54,91],"EXPERIMENTAL":[30],"DESIGN:":[31],"In":[32,111,139],"retrospective":[34,113],"analysis,":[35],"49":[36],"and":[38,73,90,108,128,156,174],"temporally":[39,131],"matched":[40,132],"samples":[42,127],"were":[48],"screened":[49,58,170],"for":[50,68,176,197,239],"by":[53,71,80,99,121,171],"then":[56],"prospectively":[57],"ctDNA":[60,129,155,196],"60":[62],"BEAMing":[72,100,122,153,175],"compared":[74],"findings":[76],"results":[78,212,236],"obtained":[79,190],"screening":[81],"corresponding":[82],"archival":[83,159,166],"tissue":[85,161,167,182],"both":[88,104,172],"sequencing":[89,157,173],"RESULTS:":[92],"The":[93],"overall":[94],"frequency":[95],"was":[101,134,150,169,185],"similar":[102],"patient":[105],"cohorts":[106],"(29%":[107],"28.3%,":[109],"respectively).":[110],"cohort,":[114,142],"concordance":[116,144,187],"mutation":[119],"status":[120,217,229],"between":[123,152],"formalin-fixed,":[124],"paraffin-embedded":[125],"(FFPE)":[126],"100%":[135,186],"(34":[136],"34).":[138],"prospective":[141],"rate":[145],"among":[146],"51":[147],"evaluable":[148],"cases":[149],"72.5%":[151],"DNA.":[162],"When":[163],"same":[165],"(n":[179],"=":[180],"41":[181],"samples),":[183],"there":[184],"results.":[191],"CONCLUSIONS:":[192],"Analysis":[193],"plasma-derived":[195],"detection":[199],"is":[209],"feasible.":[210],"Our":[211],"suggest":[213],"that":[214],"mutational":[216],"can":[218],"change":[219],"upon":[220],"disease":[221],"recurrence,":[222],"emphasizing":[223],"importance":[225],"reassessing":[227],"on":[230],"contemporary":[231],"(not":[232],"archival)":[233],"biospecimens.":[234],"These":[235],"have":[237],"implications":[238],"development":[241],"predictive":[243],"biomarkers":[244],"response":[246],"targeted":[248],"therapies.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":32},{"year":2017,"cited_by_count":47},{"year":2016,"cited_by_count":39},{"year":2015,"cited_by_count":35},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":24},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}